Apollo Life Sciences Limited
Patent Owner
Stats
- 1 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 17, 2009 most recent publication
Details
- 1 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 188 Total Citation Count
- Apr 05, 1994 Earliest Filing
- 12 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2009/0311,247 MOLECULES AND CHIMERIC MOLECULES THEREOFAbandonedNov 18, 05Dec 17, 09[A61K, C07H, G01N, C07K]
2009/0232,808 MOLECULES AND CHIMERIC MOLECULES THEREOFAbandonedJan 27, 06Sep 17, 09[A61K, C12N, G01N, C07K]
2009/0202,472 MOLECULES AND CHIMERIC MOLECULES THEREOFAbandonedNov 24, 05Aug 13, 09[A61K, C12N, G01N, C07K]
2009/0175,819 MOLECULE AND CHIMERIC MOLECULES THEREOFAbandonedFeb 14, 06Jul 09, 09[A61K, C07H, G01N, A61P, C07K]
2009/0155,267 MOLECULE AND CHIMERIC MOLECULES THEREOFAbandonedFeb 09, 06Jun 18, 09[A61K, C07H, C07K]
2009/0142,294 PARAMETER SELECTED GM-CSF, IL-3, IL-4, IL-5 AND CHIMERAS THEREOF FOR THERAPEUTIC AND DIAGNOSTIC PURPOSESAbandonedJan 25, 06Jun 04, 09[A61K, C12N, G01N, C07K]
2009/0136,444 MOLECULE AND CHIMERIC MOLECULES THEREOFAbandonedNov 11, 05May 28, 09[C07H, A61K, G01N, C07K]
2006/0127,365 Method of cell therapy using fused cell hybridsAbandonedMay 30, 03Jun 15, 06[A61K, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.